{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T14:55:22Z","timestamp":1781621722678,"version":"3.54.5"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T00:00:00Z","timestamp":1764374400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Study on the effect of early tracheal extubation combined with \u201cSix Character Technique\u201d gong method on acute lung injury after liver transplantation and its mechanism of action","award":["2022YF0258"],"award-info":[{"award-number":["2022YF0258"]}]},{"name":"Study on the effect of early tracheal extubation combined with \u201cSix Character Technique\u201d gong method on acute lung injury after liver transplantation and its mechanism of action","award":["2022YF0258"],"award-info":[{"award-number":["2022YF0258"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hereditas"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Hepatitis B virus-related acute-on-chronic liver failure (HBV-ACLF) is a clinical syndrome that presents with acute hepatic decompensation and liver failure in a relatively short time, with a high mortality rate.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>\n                      The aim was to assess the predictive value of\n                      <jats:italic>miR-223-3p<\/jats:italic>\n                      in the short-term prognosis of patients and its potential role in HBV-ACLF, thus providing new ideas for personalized treatment.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>\n                      The level of\n                      <jats:italic>miR-223-3p<\/jats:italic>\n                      was quantified using qRT-PCR. The correlation between\n                      <jats:italic>miR-223-3p<\/jats:italic>\n                      level and indicators associated with the severity of HBV-ACLF (TBil, INR, and MELD score) was assessed using Spearman\u2019s method. The prognostic value of\n                      <jats:italic>miR-223-3p<\/jats:italic>\n                      in HBV-ACLF was assessed using the ROC curve, Cox regression analysis, and Kaplan-Meier curve. To detect the proliferation and apoptosis of MIHA cells, CCK-8 assay and flow cytometry were employed. Bioinformatics methods were conducted to identify the downstream targets of\n                      <jats:italic>miR-223-3p<\/jats:italic>\n                      . The regulation between\n                      <jats:italic>miR-223-3p<\/jats:italic>\n                      and\n                      <jats:italic>HSP90B1<\/jats:italic>\n                      was validated through Dual-luciferase reporter gene assay.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In patients with HBV-ACLF,\n                      <jats:italic>miR-223-3p<\/jats:italic>\n                      expression was reduced and negatively correlated with TBil, INR, and MELD score. Low expression of\n                      <jats:italic>miR-223-3p<\/jats:italic>\n                      predicted adverse prognosis for patients. Furthermore, MELD score and\n                      <jats:italic>miR-223-3p<\/jats:italic>\n                      were identified as independent prognostic factors in patients with HBV-ACLF. In H\n                      <jats:sub>2<\/jats:sub>\n                      O\n                      <jats:sub>2<\/jats:sub>\n                      or TNF-\u03b1\u2013induced MIHA cells,\n                      <jats:italic>miR-223-3p<\/jats:italic>\n                      facilitated cellular proliferation and suppressed apoptosis. The role of\n                      <jats:italic>miR-223-3p<\/jats:italic>\n                      in hepatocyte injury was mediated by\n                      <jats:italic>HSP90B1<\/jats:italic>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Serum\n                      <jats:italic>miR-223-3p<\/jats:italic>\n                      expression was predictive for short-term survival in patients with HBV-ACLF, and\n                      <jats:italic>miR-223-3p<\/jats:italic>\n                      attenuated hepatocellular injury in vitro by modulating\n                      <jats:italic>HSP90B1<\/jats:italic>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s41065-025-00610-5","type":"journal-article","created":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T09:23:48Z","timestamp":1764408228000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["miR-223-3p predicts prognosis of hepatitis B virus-related acute-on-chronic liver failure and is involved in hepatocyte injury via HSP90B1"],"prefix":"10.1186","volume":"163","author":[{"given":"Feiyue","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuping","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menghang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,29]]},"reference":[{"key":"610_CR1","doi-asserted-by":"crossref","first-page":"1286510","DOI":"10.3389\/fmed.2023.1286510","volume":"10","author":"Y Ma","year":"2023","unstructured":"Ma Y, Du L, Zhou S, Bai L, Tang H. Association of direct bilirubin to total bilirubin ratio with 90-day mortality in patients with acute-on-chronic liver failure. Front Med (Lausanne). 2023;10:1286510.","journal-title":"Front Med (Lausanne)"},{"issue":"3","key":"610_CR2","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1097\/HEP.0000000000000354","volume":"78","author":"G Elias","year":"2023","unstructured":"Elias G, Schonfeld M, Saleh S, Parrish M, Barmanova M, Weinman SA, et al. Sepsis-induced endothelial dysfunction drives acute-on-chronic liver failure through Angiopoietin-2-HGF-C\/EBPbeta pathway. Hepatology. 2023;78(3):803\u201319.","journal-title":"Hepatology"},{"issue":"1","key":"610_CR3","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1186\/s12876-022-02371-1","volume":"22","author":"N Yao","year":"2022","unstructured":"Yao N, He Y, Wu Y, Wang F, Tian Z. Prognostic value of plasma level of superoxide dismutase in HBV-related acute-on-chronic liver failure. BMC Gastroenterol. 2022;22(1):312.","journal-title":"BMC Gastroenterol"},{"issue":"23","key":"610_CR4","doi-asserted-by":"crossref","first-page":"8186","DOI":"10.12998\/wjcc.v10.i23.8186","volume":"10","author":"QX Ye","year":"2022","unstructured":"Ye QX, Huang JF, Xu ZJ, Yan YY, Yan Y, Liu LG. Short-term prognostic factors for hepatitis B virus-related acute-on-chronic liver failure. World J Clin Cases. 2022;10(23):8186\u201395.","journal-title":"World J Clin Cases"},{"issue":"9","key":"610_CR5","doi-asserted-by":"crossref","first-page":"100848","DOI":"10.1016\/j.jhepr.2023.100848","volume":"5","author":"X Liang","year":"2023","unstructured":"Liang X, Li P, Jiang J, Xin J, Luo J, Li J, et al. Transcriptomics unveils immune metabolic disruption and a novel biomarker of mortality in patients with HBV-related acute-on-chronic liver failure. JHEP Rep. 2023;5(9):100848.","journal-title":"JHEP Rep"},{"issue":"4","key":"610_CR6","doi-asserted-by":"crossref","first-page":"300","DOI":"10.5114\/ceh.2022.122332","volume":"8","author":"A Abudeif","year":"2022","unstructured":"Abudeif A, Sayed EKA, Galal GM. Characteristics and predictors of short-term mortality in decompensated cirrhotic patients with acute-on-chronic liver failure. Clin Exp Hepatol. 2022;8(4):300\u20138.","journal-title":"Clin Exp Hepatol"},{"issue":"7","key":"610_CR7","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1080\/17474124.2022.2097070","volume":"16","author":"N Abbas","year":"2022","unstructured":"Abbas N, Rajoriya N, Elsharkawy AM, Chauhan A. Acute-on-chronic liver failure (ACLF) in 2022: have novel treatment paradigms already arrived? Expert Rev Gastroenterol Hepatol. 2022;16(7):639\u201352.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"3","key":"610_CR8","doi-asserted-by":"crossref","first-page":"e28650","DOI":"10.1002\/jmv.28650","volume":"95","author":"W Xu","year":"2023","unstructured":"Xu W, Zhu S, Yang L, Li Z, Wu L, Zhang Y, et al. Safety and efficacy of double plasma molecular adsorption system with sequential low-volume plasma exchange in intermediate-stage hepatitis B virus-related acute-on-chronic liver failure. J Med Virol. 2023;95(3):e28650.","journal-title":"J Med Virol"},{"issue":"1","key":"610_CR9","doi-asserted-by":"crossref","first-page":"21","DOI":"10.14348\/molcells.2023.2157","volume":"46","author":"H Hwang","year":"2023","unstructured":"Hwang H, Chang HR, Baek D. Determinants of functional MicroRNA targeting. Mol Cells. 2023;46(1):21\u201332.","journal-title":"Mol Cells"},{"key":"610_CR10","doi-asserted-by":"crossref","unstructured":"Wu J, Zhu Y, Cong Q, Xu Q. Non\u2013coding rnas: role of MiRNAs and LncRNAs in the regulation of autophagy in hepatocellular carcinoma (Review). Oncol Rep. 2023;49(6):113.","DOI":"10.3892\/or.2023.8550"},{"key":"610_CR11","doi-asserted-by":"crossref","first-page":"1147710","DOI":"10.3389\/fimmu.2023.1147710","volume":"14","author":"W Yu","year":"2023","unstructured":"Yu W, Wang S, Wang Y, Chen H, Nie H, Liu L, et al. MicroRNA: role in macrophage polarization and the pathogenesis of the liver fibrosis. Front Immunol. 2023;14:1147710.","journal-title":"Front Immunol"},{"issue":"2","key":"610_CR12","doi-asserted-by":"crossref","first-page":"e767","DOI":"10.1002\/iid3.767","volume":"11","author":"J Fang","year":"2023","unstructured":"Fang J, Kuang J, Hu S, Yang X, Wan W, Li J, et al. Upregulated microRNA-450b-5p represses the development of acute liver failure via modulation of liver function, inflammatory response, and hepatocyte apoptosis. Immun Inflamm Dis. 2023;11(2):e767.","journal-title":"Immun Inflamm Dis"},{"issue":"31","key":"610_CR13","doi-asserted-by":"crossref","first-page":"4706","DOI":"10.3748\/wjg.v29.i31.4706","volume":"29","author":"MH Zhang","year":"2023","unstructured":"Zhang MH, Yuan YF, Liu LJ, Wei YX, Yin WY, Zheng LZ, et al. Dysregulated MicroRNAs as a biomarker for diagnosis and prognosis of hepatitis B virus-associated hepatocellular carcinoma. World J Gastroenterol. 2023;29(31):4706\u201335.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"610_CR14","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/s41598-019-56630-5","volume":"10","author":"J Cisilotto","year":"2020","unstructured":"Cisilotto J, do Amaral AE, Rosolen D, Rode MP, Silva AH, Winter E, et al. MicroRNA profiles in serum samples from Acute-On-Chronic liver failure patients and miR-25-3p as a potential biomarker for survival prediction. Sci Rep. 2020;10(1):100.","journal-title":"Sci Rep"},{"key":"610_CR15","doi-asserted-by":"crossref","first-page":"101581","DOI":"10.1016\/j.molmet.2022.101581","volume":"65","author":"MY Hochreuter","year":"2022","unstructured":"Hochreuter MY, Dall M, Treebak JT, Barres R. MicroRNAs in non-alcoholic fatty liver disease: progress and perspectives. Mol Metab. 2022;65:101581.","journal-title":"Mol Metab"},{"issue":"1","key":"610_CR16","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1080\/21623945.2022.2098583","volume":"11","author":"Q Niu","year":"2022","unstructured":"Niu Q, Wang T, Wang Z, Wang F, Huang D, Sun H, et al. Adipose-derived mesenchymal stem cell-secreted extracellular vesicles alleviate non-alcoholic fatty liver disease via delivering miR-223-3p. Adipocyte. 2022;11(1):572\u201387.","journal-title":"Adipocyte"},{"issue":"12","key":"610_CR17","first-page":"1185","volume":"37","author":"S Li","year":"2022","unstructured":"Li S, Chen Z, Zhou R, Wang S, Wang W, Liu D, et al. Hsa_circ_0048674 facilitates hepatocellular carcinoma progression and natural killer cell exhaustion depending on the regulation of miR-223-3p\/PDL1. Histol Histopathol. 2022;37(12):1185\u201399.","journal-title":"Histol Histopathol"},{"key":"610_CR18","doi-asserted-by":"crossref","first-page":"610561","DOI":"10.3389\/fcvm.2020.610561","volume":"7","author":"MW Zhang","year":"2020","unstructured":"Zhang MW, Shen YJ, Shi J, Yu JG. MiR-223-3p in cardiovascular diseases: A biomarker and potential therapeutic target. Front Cardiovasc Med. 2020;7:610561.","journal-title":"Front Cardiovasc Med"},{"issue":"2","key":"610_CR19","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.3934\/mbe.2020079","volume":"17","author":"J Xu","year":"2019","unstructured":"Xu J, Wang B, Liu ZT, Lai MC, Zhang ML, Zheng SS. miR-223-3p regulating the occurrence and development of liver cancer cells by targeting FAT1 gene. Math Biosci Eng. 2019;17(2):1534\u201347.","journal-title":"Math Biosci Eng"},{"key":"610_CR20","doi-asserted-by":"crossref","first-page":"109808","DOI":"10.1016\/j.intimp.2023.109808","volume":"116","author":"S Tang","year":"2023","unstructured":"Tang S, Zhang X, Duan Z, Xu M, Kong M, Zheng S, et al. The novel hepatoprotective mechanisms of silibinin-phospholipid complex against d-GalN\/LPS-induced acute liver injury. Int Immunopharmacol. 2023;116:109808.","journal-title":"Int Immunopharmacol"},{"key":"610_CR21","doi-asserted-by":"crossref","first-page":"923300","DOI":"10.3389\/fcimb.2022.923300","volume":"12","author":"W Xu","year":"2022","unstructured":"Xu W, Yu M, Wu Y, Jie Y, Li X, Zeng X, et al. Plasma-Derived Exosomal SncRNA as a promising diagnostic biomarker for early detection of HBV-Related Acute-on-Chronic liver failure. Front Cell Infect Microbiol. 2022;12:923300.","journal-title":"Front Cell Infect Microbiol"},{"key":"610_CR22","unstructured":"Liver failure and artificial liver group, Chinese society of infectious diseases, Chinese medical association; severe liver disease and artificial liver group, Chinese society of hepatology, Chinese medical association. [Guideline for diagnosis and treatment of liver failure]. Zhonghua Gan Zang Bing Za Zhi. 2019;27(1):18\u201326."},{"issue":"2","key":"610_CR23","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1053\/jhep.2001.22172","volume":"33","author":"PS Kamath","year":"2001","unstructured":"Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. Hepatology. 2001;33(2):464\u201370.","journal-title":"Hepatology"},{"issue":"1","key":"610_CR24","doi-asserted-by":"crossref","first-page":"20230718","DOI":"10.1515\/med-2023-0718","volume":"18","author":"X Huang","year":"2023","unstructured":"Huang X, He X, Qiu R, Xie X, Zheng F, Chen F, et al. Unfolded protein response inhibits KAT2B\/MLKL-mediated necroptosis of hepatocytes by promoting BMI1 level to ubiquitinate KAT2B. Open Med (Wars). 2023;18(1):20230718.","journal-title":"Open Med (Wars)"},{"issue":"8","key":"610_CR25","first-page":"713","volume":"12","author":"T Gong","year":"2024","unstructured":"Gong T, Liu X, Li Q, Branch DR, Loriamini M, Wen W, et al. Oncolytic virus senecavirus A inhibits hepatocellular carcinoma proliferation and growth by inducing cell cycle arrest and apoptosis. J Clin Transl Hepatol. 2024;12(8):713\u201325.","journal-title":"J Clin Transl Hepatol"},{"issue":"3","key":"610_CR26","doi-asserted-by":"crossref","first-page":"670","DOI":"10.3350\/cmh.2022.0103","volume":"29","author":"VK Br","year":"2023","unstructured":"Br VK, Sarin SK. Acute-on-chronic liver failure: Terminology, mechanisms and management. Clin Mol Hepatol. 2023;29(3):670\u201389.","journal-title":"Clin Mol Hepatol"},{"key":"610_CR27","doi-asserted-by":"crossref","first-page":"1381386","DOI":"10.3389\/fmed.2024.1381386","volume":"11","author":"Y Ma","year":"2024","unstructured":"Ma Y, Xu Y, Du L, Bai L, Tang H. Outcome of patients with different stages of acute-on-chronic liver failure treated with artificial liver support system. Front Med (Lausanne). 2024;11:1381386.","journal-title":"Front Med (Lausanne)"},{"issue":"9","key":"610_CR28","first-page":"1004","volume":"31","author":"YJ Ma","year":"2023","unstructured":"Ma YJ, Du LY, Bai L, Tang H. [Research progress of non-biological artificial liver support system therapy for paitents with liver failure]. Zhonghua Gan Zang Bing Za Zhi. 2023;31(9):1004\u20138.","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"610_CR29","first-page":"8814841","volume":"2020","author":"H Liu","year":"2020","unstructured":"Liu H, Li Y, Gao F, Meng P, Yu H, Wu T, et al. Serum clusterin: A potential marker for assessing the clinical severity and Short-Term prognosis of hepatitis B Virus-Related Acute-on-Chronic liver failure. Dis Markers. 2020;2020:8814841.","journal-title":"Dis Markers"},{"issue":"1","key":"610_CR30","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1038\/s41598-024-52206-0","volume":"14","author":"X Cheng","year":"2024","unstructured":"Cheng X, Zhan Y, Liu Y, Zeng X, Wang Z, Wang F, et al. A clinical study of non-bioartificial liver DPMAES support system in hepatitis B-related acute-on-chronic liver failure. Sci Rep. 2024;14(1):1772.","journal-title":"Sci Rep"},{"issue":"2","key":"610_CR31","doi-asserted-by":"crossref","first-page":"2287708","DOI":"10.1080\/07853890.2023.2287708","volume":"55","author":"L Liu","year":"2023","unstructured":"Liu L, Chen P, Xiao N, Liu Q, Zhu X. Interleukin-8 predicts short-term mortality in acute-on-chronic liver failure patients with hepatitis B-related-related cirrhosis background. Ann Med. 2023;55(2):2287708.","journal-title":"Ann Med"},{"issue":"1","key":"610_CR32","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1186\/s13054-023-04540-4","volume":"27","author":"J Luo","year":"2023","unstructured":"Luo J, Li J, Li P, Liang X, Hassan HM, Moreau R, et al. Acute-on-chronic liver failure: Far to go-a review. Crit Care. 2023;27(1):259.","journal-title":"Crit Care"},{"issue":"1","key":"610_CR33","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1186\/s12876-020-01437-2","volume":"20","author":"L Qiang","year":"2020","unstructured":"Qiang L, Qin J, Sun C, Sheng Y, Chen W, Qiu B, et al. A novel predictive model based on inflammatory markers to assess the prognosis of patients with HBV-related acute-on-chronic liver failure: a retrospective cohort study. BMC Gastroenterol. 2020;20(1):301.","journal-title":"BMC Gastroenterol"},{"key":"610_CR34","doi-asserted-by":"crossref","unstructured":"Ingustu DG, Pavel B, Paltineanu SI, Mihai DI, Cotorogea-Simion M, Martac C et al. The management of postoperative cognitive dysfunction in cirrhotic patients: an overview of the literature. Med (Kaunas). 2023;59(3):465.","DOI":"10.3390\/medicina59030465"},{"issue":"2","key":"610_CR35","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.ymthe.2019.09.013","volume":"28","author":"C Jimenez Calvente","year":"2020","unstructured":"Jimenez Calvente C, Del Pilar H, Tameda M, Johnson CD, Feldstein AE. MicroRNA 223 3p negatively regulates the NLRP3 inflammasome in acute and chronic liver injury. Mol Ther. 2020;28(2):653\u201363.","journal-title":"Mol Ther"},{"issue":"4","key":"610_CR36","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1007\/s12072-023-10513-0","volume":"17","author":"S Zhang","year":"2023","unstructured":"Zhang S, Yu J, Rao K, Cao J, Ma L, Yu Y, et al. Liver-derived extracellular vesicles from patients with hepatitis B virus-related acute-on-chronic liver failure impair hepatic regeneration by inhibiting on FGFR2 signaling via miR-218-5p. Hepatol Int. 2023;17(4):833\u201349.","journal-title":"Hepatol Int"},{"key":"610_CR37","doi-asserted-by":"crossref","first-page":"105510","DOI":"10.1016\/j.antiviral.2022.105510","volume":"211","author":"J Wang","year":"2023","unstructured":"Wang J, Zhang X, Han J, Zhou P, Yu X, Shen Z, et al. MicroRNA-124 expression in Kupffer cells modulates liver injury by targeting IL-6\/STAT3 signaling. Antiviral Res. 2023;211:105510.","journal-title":"Antiviral Res"},{"issue":"1","key":"610_CR38","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1186\/s12890-024-03170-y","volume":"24","author":"J Fang","year":"2024","unstructured":"Fang J, Xu Y, Lin C, Yang J, Zhai D, Zhuang Q, et al. Increasing serum miR-223-3p indicates the onset, severe development, and adverse prognosis of bronchiectasis: a retrospective study. BMC Pulm Med. 2024;24(1):354.","journal-title":"BMC Pulm Med"},{"issue":"7","key":"610_CR39","doi-asserted-by":"crossref","first-page":"e24506","DOI":"10.1002\/jcla.24506","volume":"36","author":"BH Peng","year":"2022","unstructured":"Peng BH, Ji YF, Qiu XJ. LncRNA PITPNA-AS1\/miR-223-3p\/PTN axis regulates malignant progression and stemness in lung squamous cell carcinoma. J Clin Lab Anal. 2022;36(7):e24506.","journal-title":"J Clin Lab Anal"},{"issue":"4","key":"610_CR40","doi-asserted-by":"crossref","first-page":"e0232211","DOI":"10.1371\/journal.pone.0232211","volume":"15","author":"P Pratedrat","year":"2020","unstructured":"Pratedrat P, Chuaypen N, Nimsamer P, Payungporn S, Pinjaroen N, Sirichindakul B, et al. Diagnostic and prognostic roles of Circulating miRNA-223-3p in hepatitis B virus-related hepatocellular carcinoma. PLoS ONE. 2020;15(4):e0232211.","journal-title":"PLoS ONE"},{"issue":"4","key":"610_CR41","doi-asserted-by":"crossref","first-page":"912","DOI":"10.3350\/cmh.2022.0121","volume":"28","author":"D Wu","year":"2022","unstructured":"Wu D, Rao Q, Xie Z, Zhu X, Che Y, Wu J, et al. Decreased vitamin D-binding protein level portends poor outcome in acute-on-chronic liver failure caused by hepatitis B virus. Clin Mol Hepatol. 2022;28(4):912\u201325.","journal-title":"Clin Mol Hepatol"},{"key":"610_CR42","doi-asserted-by":"crossref","first-page":"1370025","DOI":"10.3389\/fnut.2024.1370025","volume":"11","author":"R Song","year":"2024","unstructured":"Song R, Wang X, Li Z, Wu H, Tan J, Tan J, et al. ALTA: a simple nutritional prognostic score for patients with hepatitis B virus-related acute-on-chronic liver failure. Front Nutr. 2024;11:1370025.","journal-title":"Front Nutr"},{"key":"610_CR43","doi-asserted-by":"crossref","first-page":"705683","DOI":"10.3389\/fmolb.2021.705683","volume":"8","author":"S Ma","year":"2021","unstructured":"Ma S, Xie Z, Zhang L, Yang Y, Jiang H, Ouyang X, et al. Corrigendum: identification of a potential miRNA-mRNA regulatory network associated with the prognosis of HBV-ACLF. Front Mol Biosci. 2021;8:705683.","journal-title":"Front Mol Biosci"},{"issue":"1","key":"610_CR44","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1186\/s12879-023-08865-x","volume":"23","author":"XF Ji","year":"2023","unstructured":"Ji XF, Zhou Q, Wang JW, Sun F, Gao S, Wang K. Associations of Wnt5a expression with liver injury in chronic hepatitis B virus infection. BMC Infect Dis. 2023;23(1):860.","journal-title":"BMC Infect Dis"},{"key":"610_CR45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-0716-2823-2_1","volume":"2595","author":"A Vishnoi","year":"2023","unstructured":"Vishnoi A, Rani S. MiRNA biogenesis and regulation of diseases: an updated overview. Methods Mol Biol. 2023;2595:1\u201312.","journal-title":"Methods Mol Biol"},{"issue":"23","key":"610_CR46","doi-asserted-by":"crossref","first-page":"3288","DOI":"10.1080\/15384101.2019.1673633","volume":"18","author":"C Fang","year":"2019","unstructured":"Fang C, Xu L, He W, Dai J, Sun F. Long noncoding RNA DLX6-AS1 promotes cell growth and invasiveness in bladder cancer via modulating the miR-223-HSP90B1 axis. Cell Cycle. 2019;18(23):3288\u201399.","journal-title":"Cell Cycle"},{"issue":"3","key":"610_CR47","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3892\/etm.2021.9672","volume":"21","author":"C Tong","year":"2021","unstructured":"Tong C, Li J, Lin W, Cen W, Zhang W, Zhu Z, et al. Inhibition of heat shock protein 90 alleviates cholestatic liver injury by decreasing IL-1beta and IL-18 expression. Exp Ther Med. 2021;21(3):241.","journal-title":"Exp Ther Med"},{"issue":"2","key":"610_CR48","doi-asserted-by":"crossref","first-page":"e0193003","DOI":"10.1371\/journal.pone.0193003","volume":"13","author":"J Cosin-Roger","year":"2018","unstructured":"Cosin-Roger J, Spalinger MR, Ruiz PA, Stanzel C, Terhalle A, Wolfram L, et al. Gp96 deficiency affects TLR4 functionality and impairs ERK and p38 phosphorylation. PLoS ONE. 2018;13(2):e0193003.","journal-title":"PLoS ONE"},{"issue":"7","key":"610_CR49","doi-asserted-by":"crossref","first-page":"e68997","DOI":"10.1371\/journal.pone.0068997","volume":"8","author":"X Li","year":"2013","unstructured":"Li X, Liu Z, Yan X, Zhang X, Li Y, Zhao B, et al. Induction of regulatory T cells by high-dose gp96 suppresses murine liver immune hyperactivation. PLoS ONE. 2013;8(7):e68997.","journal-title":"PLoS ONE"},{"issue":"6","key":"610_CR50","first-page":"3044","volume":"90","author":"MH Jee","year":"2015","unstructured":"Jee MH, Hong KY, Park JH, Lee JS, Kim HS, Lee SH, et al. New mechanism of hepatic fibrogenesis: hepatitis C virus infection induces transforming growth factor beta1 production through Glucose-Regulated protein 94. J Virol. 2015;90(6):3044\u201355.","journal-title":"J Virol"},{"key":"610_CR51","doi-asserted-by":"crossref","first-page":"3434","DOI":"10.12659\/MSM.894169","volume":"21","author":"L Song","year":"2015","unstructured":"Song L, Wang Y, Wang J, Yang F, Li X, Wu Y. Trinitrotoluene induces Endoplasmic reticulum stress and apoptosis in HePG2 cells. Med Sci Monit. 2015;21:3434\u201341.","journal-title":"Med Sci Monit"},{"issue":"4","key":"610_CR52","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s12072-019-09946-3","volume":"13","author":"SK Sarin","year":"2019","unstructured":"Sarin SK, Choudhury A, Sharma MK, Maiwall R, Al Mahtab M, Rahman S, et al. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update. Hepatol Int. 2019;13(4):353\u201390.","journal-title":"Hepatol Int"},{"issue":"29","key":"610_CR53","doi-asserted-by":"crossref","first-page":"4288","DOI":"10.3748\/wjg.v26.i29.4288","volume":"26","author":"Y Chang","year":"2020","unstructured":"Chang Y, Liu QY, Zhang Q, Rong YM, Lu CZ, Li H. Role of nutritional status and nutritional support in outcome of hepatitis B virus-associated acute-on-chronic liver failure. World J Gastroenterol. 2020;26(29):4288\u2013301.","journal-title":"World J Gastroenterol"},{"issue":"23","key":"610_CR54","doi-asserted-by":"crossref","first-page":"3678","DOI":"10.3748\/wjg.v29.i23.3678","volume":"29","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Chen P, Zhu X. Lymphocyte-to-white blood cell ratio is associated with outcome in patients with hepatitis B virus-related acute-on-chronic liver failure. World J Gastroenterol. 2023;29(23):3678\u201387.","journal-title":"World J Gastroenterol"},{"issue":"44","key":"610_CR55","doi-asserted-by":"crossref","first-page":"6527","DOI":"10.3748\/wjg.v25.i44.6527","volume":"25","author":"H Li","year":"2019","unstructured":"Li H, Zhao XK, Cheng YJ, Zhang Q, Wu J, Lu S, et al. Gasdermin D-mediated hepatocyte pyroptosis expands inflammatory responses that aggravate acute liver failure by upregulating monocyte chemotactic protein 1\/CC chemokine receptor-2 to recruit macrophages. World J Gastroenterol. 2019;25(44):6527\u201340.","journal-title":"World J Gastroenterol"},{"key":"610_CR56","doi-asserted-by":"crossref","first-page":"988668","DOI":"10.3389\/fimmu.2022.988668","volume":"13","author":"YC Tao","year":"2022","unstructured":"Tao YC, Wang YH, Wang ML, Jiang W, Wu DB, Chen EQ, et al. Upregulation of microRNA-125b-5p alleviates acute liver failure by regulating the Keap1\/Nrf2\/HO-1 pathway. Front Immunol. 2022;13:988668.","journal-title":"Front Immunol"},{"key":"610_CR57","doi-asserted-by":"crossref","unstructured":"Ganjali S, Aghaee-Bakhtiari SH, Reiner Z, Sahebkar A. Differential expression of miRNA-223 in coronary In-Stent restenosis. J Clin Med. 2022;11(3):849.","DOI":"10.3390\/jcm11030849"},{"issue":"12","key":"610_CR58","first-page":"906","volume":"42","author":"FB Lu","year":"2019","unstructured":"Lu FB, Chen DZ, Chen L, Hu ED, Wu JL, Li H, et al. Attenuation of experimental autoimmune hepatitis in mice with bone mesenchymal stem Cell-Derived exosomes carrying MicroRNA-223-3p. Mol Cells. 2019;42(12):906\u201318.","journal-title":"Mol Cells"}],"container-title":["Hereditas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41065-025-00610-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41065-025-00610-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41065-025-00610-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T14:11:43Z","timestamp":1781619103000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s41065-025-00610-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,29]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["610"],"URL":"https:\/\/doi.org\/10.1186\/s41065-025-00610-5","relation":{},"ISSN":["1601-5223"],"issn-type":[{"value":"1601-5223","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,29]]},"assertion":[{"value":"10 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by The Ethics Committee of West China Hospital of Sichuan University. All procedures performed in studies involving human participants were in accordance with the 1964 Helsinki Declaration and later versions. In addition, for investigations involving human subjects, informed consent has been obtained from the participants involved.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All patients provided written informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6"}}